Suppr超能文献

中国南方多药耐药临床分离株中与吡嗪酰胺耐药相关的新基因突变检测

Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant Clinical Isolates in Southern China.

作者信息

Hameed Hm Adnan, Tan Yaoju, Islam Md Mahmudul, Lu Zhili, Chhotaray Chiranjibi, Wang Shuai, Liu Zhiyong, Fang Cuiting, Tan Shouyong, Yew Wing Wai, Zhong Nanshan, Liu Jianxiong, Zhang Tianyu

机构信息

State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences (CAS), Guangzhou, People's Republic of China.

University of Chinese Academy of Sciences (UCAS), Beijing, People's Republic of China.

出版信息

Infect Drug Resist. 2020 Jan 22;13:217-227. doi: 10.2147/IDR.S230774. eCollection 2020.

Abstract

OBJECTIVE

Pyrazinamide (PZA) is a cornerstone of modern tuberculosis regimens. This study aimed to investigate the performance of genotypic testing of upstream region, and genes to add insights for more accurate molecular diagnosis of PZA-resistant (R)

METHODS

Drug susceptibility testing, sequencing analysis of PZA-related genes including the entire operon of () and PZase assay were performed for 448 clinical isolates.

RESULTS

Our data showed that among 448 clinical isolates, 113 were MDR, 195 pre-XDR and 70 XDR TB, while the remaining 70 strains had other combinations of drug-resistance. A total of 60.04% (269/448) clinical isolates were resistant to PZA, of which 78/113 were MDR, 119/195 pre-XDR and 29/70 XDR TB strains. PZA isolates have predominance (83.3%) of Beijing genotype. Genotypic characterization of revealed novel nonsynonymous mutations in with negative PZase activity which led to confer PZA. Compared with phenotypic data, 84.38% (227/269) PZA strains with mutations in upstream region exhibited 83.64% sensitivity but the combined evaluation of the mutations in 2.60% (7/269), 1.48% (4/269), 1.11% (3/269) and 0.74% (2/269) increased the sensitivity to 89.59%. Fifty-seven novel mutations were identified in this study. Interestingly, a frameshift deletion (C-114del) in upstream of nullified the effect of A-11G mutation and induced positive PZase activity, divergent from five PZase negative A-11G PZA mutants. Twenty-six PZA strains having wild-type-sequenced genes with positive or negative PZase suggest the existence of unknown resistance mechanisms.

CONCLUSION

Our study revealed that PZA rate in MDR and pre-XDR TB was markedly higher in southern China. The concomitant evaluation of UFR, and provides more dependable genotypic results of PZA resistance. Fifty-seven novel mutations/indels in this study may play a vital role as diagnostic markers. The upstream region of and PZase regulation are valuable to explore the unknown mechanism of PZA-resistance.

摘要

目的

吡嗪酰胺(PZA)是现代结核病治疗方案的基石。本研究旨在调查上游区域及相关基因的基因分型检测性能,为更准确的耐PZA分子诊断提供见解。

方法

对448株临床分离株进行药敏试验、包括整个操纵子在内的PZA相关基因测序分析及PZase检测。

结果

我们的数据显示,在448株临床分离株中,113株为耐多药(MDR),195株为广泛耐药前(pre-XDR),70株为广泛耐药(XDR)结核病,其余70株有其他耐药组合。共有60.04%(269/448)的临床分离株对PZA耐药,其中78/113为MDR,119/195为pre-XDR,29/70为XDR结核菌株。耐PZA分离株以北京基因型为主(83.3%)。基因分型特征显示,在具有阴性PZase活性的中发现了新的非同义突变,导致对PZA耐药。与表型数据相比,84.38%(227/269)在上游区域有突变的PZA菌株表现出83.64%的敏感性,但对、、和中突变的综合评估将敏感性提高到89.59%。本研究共鉴定出57个新突变。有趣的是,上游的一个移码缺失(C-114del)消除了A-11G突变的影响并诱导了阳性PZase活性,这与五个PZase阴性的A-11G PZA突变体不同。26株具有野生型测序基因且PZase呈阳性或阴性的PZA菌株表明存在未知的耐药机制。

结论

我们的研究表明,中国南方MDR和pre-XDR结核病中的PZA耐药率明显更高。对上游区域、及的联合评估可提供更可靠的PZA耐药基因分型结果。本研究中的57个新突变/插入缺失可能作为诊断标志物发挥重要作用。的上游区域和PZase调控对于探索PZA耐药的未知机制具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cce/6986415/c1f4cd493184/IDR-13-217-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验